EP0907318A4 - Antioxidierende verbindung - Google Patents
Antioxidierende verbindungInfo
- Publication number
- EP0907318A4 EP0907318A4 EP97922494A EP97922494A EP0907318A4 EP 0907318 A4 EP0907318 A4 EP 0907318A4 EP 97922494 A EP97922494 A EP 97922494A EP 97922494 A EP97922494 A EP 97922494A EP 0907318 A4 EP0907318 A4 EP 0907318A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antioxidant compound
- antioxidant
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1647696P | 1996-04-29 | 1996-04-29 | |
US16476P | 1996-04-29 | ||
PCT/US1997/007037 WO1997040680A1 (en) | 1996-04-29 | 1997-04-25 | Antioxidant compound |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0907318A1 EP0907318A1 (de) | 1999-04-14 |
EP0907318A4 true EP0907318A4 (de) | 2000-02-02 |
Family
ID=21777334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97922494A Withdrawn EP0907318A4 (de) | 1996-04-29 | 1997-04-25 | Antioxidierende verbindung |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0907318A4 (de) |
JP (1) | JP2000510110A (de) |
WO (1) | WO1997040680A1 (de) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4234595A (en) * | 1977-07-13 | 1980-11-18 | Mead Johnson & Company | 3-Indolyl-tertiary butylaminopropanols |
WO1994012178A1 (en) * | 1992-12-01 | 1994-06-09 | Smithkline Beecham Corporation | Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5405863A (en) * | 1992-12-01 | 1995-04-11 | Smithkline Beecham Corporation | Antioxidant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
-
1997
- 1997-04-25 JP JP09539096A patent/JP2000510110A/ja active Pending
- 1997-04-25 WO PCT/US1997/007037 patent/WO1997040680A1/en not_active Application Discontinuation
- 1997-04-25 EP EP97922494A patent/EP0907318A4/de not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4234595A (en) * | 1977-07-13 | 1980-11-18 | Mead Johnson & Company | 3-Indolyl-tertiary butylaminopropanols |
WO1994012178A1 (en) * | 1992-12-01 | 1994-06-09 | Smithkline Beecham Corporation | Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
Non-Patent Citations (5)
Title |
---|
BRISTOW, O'CONNELL, GILBERT: "dose-response of chronic beta-blocker treatment in heart failure...", CIRCULATION, no. 89, 1994, pages 1632 - 1642, XP000863212 * |
G Z FEUERSTEIN ET AL: "Carvedilol Update III. Rationale for use in congestive heart failure", DRUGS OF TODAY / MEDICAMENTOS DE ACTUALIDAD,ES,J.R. PROUS SS.A. INTERNATIONAL PUBLISHERS, vol. 31, no. SUPPL. F, pages 1-23, XP002039368, ISSN: 0025-7656 * |
GILBERT E M, ANDERSON J L: "long term beta blocker vasodilator therapy improved cardiac functioning in idiopathic", AMER J MED, vol. 88, 1990, pages 223 - 229, XP000862858 * |
See also references of WO9740680A1 * |
WOODLEY,GILBERT,ANDERSON: "beta-blockade with bucindolol in heart failure caused by ischemic versus...", CIRCULATION, no. 84, 1991, pages 2426 - 2441, XP000863213 * |
Also Published As
Publication number | Publication date |
---|---|
EP0907318A1 (de) | 1999-04-14 |
JP2000510110A (ja) | 2000-08-08 |
WO1997040680A1 (en) | 1997-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9607120D0 (en) | Compounds | |
AUPN842196A0 (en) | New compound | |
AUPN955596A0 (en) | New compound | |
GB9602326D0 (en) | Compounds | |
AUPO381496A0 (en) | New compound | |
GB9612153D0 (en) | Compounds | |
AUPO440596A0 (en) | New compound | |
ZA9711052B (en) | Antioxidant | |
GB9601356D0 (en) | Novel compound | |
AUPO371596A0 (en) | New compound | |
HU9600847D0 (en) | New compound | |
ZA9711053B (en) | Antioxidant Antioxidant | |
EP0907318A4 (de) | Antioxidierende verbindung | |
ZA9711054B (en) | Antioxidant | |
GB9600894D0 (en) | Novel compound | |
GB9600886D0 (en) | Novel compound | |
GB9720305D0 (en) | Compound | |
GB9606933D0 (en) | Compounds | |
AU2686197A (en) | Arylalkylpiperazine compounds as antioxidants | |
GB9605803D0 (en) | Pharmaceutically-active compound | |
AUPN885496A0 (en) | New compound | |
AUPN801096A0 (en) | New compound | |
AUPN983596A0 (en) | New compound | |
AUPO439096A0 (en) | New compound | |
GB9603432D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19981023 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): BE CH DE ES FR GB IT LI NL |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19991222 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): BE CH DE ES FR GB IT LI NL |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20000301 |